Chase Coleman’s DexCom DXCM Stock Holding History

Chase Coleman’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,152,806	Closed	-$131M	–	46
2024 Q2	$131M	Hold	1,152,806	–	–	0.6%	28
2024 Q1	$160M	Hold	1,152,806	–	–	0.87%	25
2023 Q4	$143M	Buy	+1,152,806	New	+$118M	1.02%	23

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Chase Coleman's DXCM Position: Q3 2024 in Review

Chase Coleman sold out of DexCom (DXCM) in Q3 2024, closing a stake of 1,152,806 shares — an estimated $131M sold.

Chase Coleman first reported a position in DXCM in Q4 2023 and held it in 3 quarters. The position peaked at $160M in Q1 2024. 890 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

Chase Coleman reported no remaining DexCom position as of Q3 2024 after selling out during the quarter.
Chase Coleman sold 1,152,806 DexCom shares in Q3 2024, an estimated $131M.
Chase Coleman first reported a position in DexCom in Q4 2023 and held it in 3 quarters.
Chase Coleman's DexCom position peaked at $160M in Q1 2024.
890 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on Tiger Global Management's 13F filing for Q3 2024, filed 14 Nov 2024.